Merck & Co. Inc. v. Mediplan Health Consulting Inc.

Canadian Pharmacies' Use of Mark Not a Fair Use Under Lanham Act Comparative Advertising Exception

This article requires premium access

This article requires premium access to The New York Law Journal. Please sign in or subscribe to read the full text.